BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35889923)

  • 1. Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease.
    Gupta A; Singh K; Fatima S; Ambreen S; Zimmermann S; Younis R; Krishnan S; Rana R; Gadi I; Schwab C; Biemann R; Shahzad K; Rani V; Ali S; Mertens PR; Kohli S; Isermann B
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
    Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
    Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 activation induced by neutrophil extracellular traps sustains inflammatory response in the diabetic wound.
    Liu D; Yang P; Gao M; Yu T; Shi Y; Zhang M; Yao M; Liu Y; Zhang X
    Clin Sci (Lond); 2019 Feb; 133(4):565-582. PubMed ID: 30626731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
    Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
    Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Extracellular Traps Induce Glomerular Endothelial Cell Dysfunction and Pyroptosis in Diabetic Kidney Disease.
    Zheng F; Ma L; Li X; Wang Z; Gao R; Peng C; Kang B; Wang Y; Luo T; Wu J; Yang Y; Gong L; Li Q; Yang S; Hu J
    Diabetes; 2022 Dec; 71(12):2739-2750. PubMed ID: 36095260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease.
    Yang X; Chen Z; Luo Z; Yang D; Hao Y; Hu J; Feng J; Zhu Z; Luo Q; Zhang Z; Liang W; Ding G
    Cell Signal; 2023 Sep; 109():110777. PubMed ID: 37329999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products in attenuating renal inflammation
    Wang Y; Sui Z; Wang M; Liu P
    Front Immunol; 2023; 14():1196016. PubMed ID: 37215100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
    Chen Y; Wang L; Pitzer AL; Li X; Li PL; Zhang Y
    J Mol Med (Berl); 2016 Dec; 94(12):1335-1347. PubMed ID: 27783111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
    Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
    J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cell-Derived Exosomes Ameliorate Diabetic Kidney Disease Through the NLRP3 Signaling Pathway.
    Wang Y; Liu J; Wang H; Lv S; Liu Q; Li S; Yang X; Liu G
    Stem Cells; 2023 Apr; 41(4):368-383. PubMed ID: 36682034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis.
    Kong X; Zhao Y; Wang X; Yu Y; Meng Y; Yan G; Yu M; Jiang L; Song W; Wang B; Wang X
    Chem Biol Interact; 2023 Sep; 382():110640. PubMed ID: 37473909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
    Yang M; Zhao L
    Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK-Ay mice.
    Oda K; Miyamoto S; Kodera R; Wada J; Shikata K
    J Diabetes Investig; 2023 Feb; 14(2):205-220. PubMed ID: 36308062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile Conditions.
    Münzer P; Negro R; Fukui S; di Meglio L; Aymonnier K; Chu L; Cherpokova D; Gutch S; Sorvillo N; Shi L; Magupalli VG; Weber ANR; Scharf RE; Waterman CM; Wu H; Wagner DD
    Front Immunol; 2021; 12():683803. PubMed ID: 34122445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Protein C Ameliorates Tubular Mitochondrial Reactive Oxygen Species and Inflammation in Diabetic Kidney Disease.
    Rana R; Manoharan J; Gupta A; Gupta D; Elwakiel A; Khawaja H; Fatima S; Zimmermann S; Singh K; Ambreen S; Gadi I; Biemann R; Jiang S; Shahzad K; Kohli S; Isermann B
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome.
    Ma Z; Zhu L; Wang S; Guo X; Sun B; Wang Q; Chen L
    Ren Fail; 2022 Dec; 44(1):923-932. PubMed ID: 35618411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.
    Li L; Qian K; Sun Y; Zhao Y; Zhou Y; Xue Y; Hong X
    Bioengineered; 2021 Dec; 12(1):4805-4815. PubMed ID: 34338149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of diabetic vascular endothelial dysfunction: Hypoadiponectinemia-induced NLRP3 inflammasome activation.
    Zhang J; Xia L; Zhang F; Zhu D; Xin C; Wang H; Zhang F; Guo X; Lee Y; Zhang L; Wang S; Guo X; Huang C; Gao F; Liu Y; Tao L
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1556-1567. PubMed ID: 28216285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.